CCR5/Δccr5 heterozygosity: A selective pressure for the syncytium- Inducing human immunodeficiency virus type 1 phenotype

Journal of Infectious Diseases

Volumn 177, Issue 6, 1998, Pages 1549-1553

  D'Aquila, Richard T ^a   Sutton, Lorraine ^b   Savara, Anu ^b   Hughes, Michael D ^b   Johnson, Victoria A ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS MUTATION;

EID: 0031781607     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515307     Document Type: Article

References (14)

1. Connor RI, Sheridan KE, Ceradini D, Choc S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997;184:621-8.
2. + cell depletion and progression to AIDS. Ann Intern Med 1993;118:681-8.
3. Koot M, van 't Wout AB, Kootstra NA, de Goede RE, Tersmette M, Schuitemaker H. Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection. J Infect Dis 1996;173:349-54.
4. Bozzette SA, McCutchan JA, Spector SA, Wright B, Richman DD. A cross-sectional comparison of persons with syncytium- and non-syncytium-inducing human immunodeficiency virus. J Infect Dis 1993;168:1374-9.
5. Richman DD, Bozzette SA. The impact of syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 1994;169:968-74.
6. Scarlatti G, Tresoldi E, Bjorndal A, et al. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nature Med 1997;3:1259-65.
7. Leigh Brown AJ, Richman DD. HIV-1: gambling on the evolution of drug resistance? Nature Med 1997;3:268-71.
8. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-7.
9. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
10. Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-6.
11. Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion co-receptor for macrophage-tropic HIV-1. Science 1996;272:1955-8.
12. Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996;382:833-5.
13. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996;382:829-33.
14. Bleul CC, Fuhlbrigge RC, Casanovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996;184:1101-10.